All attending UK organisations

UK companies attending BIO-Europe Spring 2019 as part of the official delegation

(Click here to search profiles): Albumedix, Arcinova, BIA (UK BioIndustry Association), Bionow, BioPartner UK, Clinical Network Services, Fusion Antibodies, Healx, Immupharma, Karma Oncology, MediWales, Neem Biotech, OBN (UK), One Nucleus, Oxstem, Precision for Medicine Oncology and Rare Diseases, Scottish Development International, Selcia, SYNthesis Research

UK Exhibitors
Abzena, Barrington James, BioPartner UK, Black Swan Analysis, Brooks Life Sciences, Cello Health, FUJIFILM Diosynth, GlobalData, Pharma Intelligence Informa, National Institute for Health Research, Quotient Sciences, Random42, SQN Clinical, Worldwide Clinical Trials.

UK stand (booth #5) and Regional Groups:
BioPartner UK: UK stand booth #5a and #6, National Institute for Health Research: booth #5b, SQN Clinical (Syne Qua Non): booth #4

Other UK companies associated with the delegation*:

Abzena, Alacrita Consulting, Alderley Analytical, Alderley Park, Almac Group, Alsa Holdings, AMR Centre, Aptus Clinical, Aspire Pharma, AstraZeneca, Artios Pharma, Catalyst Advisors, Cello Health Consulting, Chronos Therapeutics, CIMYM Biosciences, Circassia Pharmaceuticals, Clinical Accelerator, CN Bio Innovations, Crystec, e Therapeutics, ERA Consulting UK, HC Pharma Consultancy, HungaroTrial, IDACO Consulting, J A Kemp, Leaf Systems International, Medherant, MEDICXI, Medisieve, MGB Biopharma, Mironid, Napp Pharmaceuticals, PHASTAR, ProAxsis, Quay Pharmaceuticals, RedX Pharma, SBA, Sekisui, Shanghai Medicilon, Silence Therapeutics, Sygnature Discovery, Syne Qua Non, Takeda, Tissue Solutions, TopiVert Pharma, Vaccitech, Valo Therapeutics, Venn Life Sciences

UK Presenting companies:

Bridge Biotec, Igem Therapeutics, Maxcyte, Medherant, ProteinLogic, Reneuron

All attending UK companies:

2A Pharma, 3M United Kingdom, 4D Pharma, Abzena, Accord Healthcare, Adiuvo Investments, AG Biosolutions, Akari Therapeutics, Alacrita Consulting, Albumedix, Alderley Analytical, Alderley Park, Almac Group, Alsa holdings, AMR Centre, Apex Healthcare Consulting, Aptus Clinical, Arcinova, Artios Pharma, Aspire Pharma, Astellas Pharma Europe, Aston University, AstraZeneca/MedImmune, Atlantic Healthcare, Barrington James, BenevolentAI, Bicycle Tx, BioPartner UK, Bionow, Biotrial International, Black Swan Analysis, Bridge Biotec, Cambridge Cognition, Cancer Research UK, Carmichael Fisher, Catalyst Advisors, Cell Medica, Cello Health BioConsulting, Centre for Process Innovation, ChilliBean, Chronos Therapeutics, CIMYM Biosciences, Circassia Pharmaceuticals, Clarivate Analytics, CLINICAL ACCELERATOR, Clinical Network Services, Clinigen, CN Bio Innovations, Consilient Health, Coulter Partners, Covance, Crescendo Biologics, Crystec, CTI, CV6 Therapeutics, Destiny Pharma, Drug Discovery Unit, Dyadic International, e Therapeutics, Elasmogen, Eli Lilly and Company, Enterprise Therapeutics, ERA Consulting UK, Evaluate, Evotec International, Excivion, Exploristics, F-star Biotechnology, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, GalbraithWight, Galen, Global Innovation Forum, GlobalData, Greenhill & Co, Grey Wolf Therapeutics, HC Pharma Consultancy, HealthCare Royalty Partners, Healx, HungaroTrial, IAG, IDACO Consulting, IGEM Therapeutics, ImmuPharma, Inceptua, Iontas, IQVIA Information Solutions, Isogenica, J+D Forecasting, Johnson & Johnson, Karma Oncology, KNect365, Kyowa Kirin International, Lamellar Biomedical, Leaf Systems International, Locust Walk, McDermott Will & Emery, Medherant, MEDICXI, Medimmune, MediSieve, MediWales, MedPharm, Mereo BioPharma, Metrion Biosciences, MGB Biopharma, Mironid, Mitsubishi Tanabe Pharma, Morvus Technology, MSD, Mundipharma Research, Napp Pharmaceuticals, National Institute for Health Research, Nature Research, Neem Biotech, NeoPhore, Norgine Ventures, NorthWest EHealth, Novintum Bioscience, NZP UK, OBN, One Nucleus, Ono Pharma, Onyx Scientific, Orbit Discovery, Ossianix, Oval Medical Technologies, OxSonics Therapeutics, OxStem, Oxyrane, PAREXEL, Pfizer, Pharm-Olam, Pharma Intelligence - Informa, Pharma Ventures, PharmaCircle, Pharmalicensing, Phastar, Precision for Medicine, ProAxsis, ProClinical, ProteinLogic, Quay Pharmaceuticals, Quotient Sciences, Random42, Redx Pharma, ReNeuron, Results Healthcare, Rosemont Pharmaceuticals, Rothschild & Co, Sachs Associates, Sage Healthcare, Samedan, Samsung Venture Investment, Sartorius Stedim, SBA, Scancell, Scius Communications, Scottish Development International, Sekisui, Selcia, Silence Therapeutics, Simcere UK, Sosei Heptares, Springer Nature, SQN Clinical, Summit Therapeutics, Sygnature Discovery, Syneos Health, SYNthesis Research, Teijin Pharma, The Fulford Group, Thermo Fisher Scientific,Pharma Services, Tissue Solutions, Topivert Pharma, Torreya, TranScrip, Treehill Partners, Ubiquigent, UK BioIndustry Association (BIA), Ulster University, Vaccitech, Valo Therapeutics, Velocity Fund Partners / InClinica, Veriton Pharma, Vernalis, VirdisGroup, WG Partners, William Reed, Worldwide Clinical Trials

195, correct at 18th March 2019

Join them here!